These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 17958845

  • 1. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [Abstract] [Full Text] [Related]

  • 2. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [Abstract] [Full Text] [Related]

  • 3. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D, Kanwar AJ, Kumar B.
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [Abstract] [Full Text] [Related]

  • 4. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E, Taştan HB, Erbil AH, Sezer E, Koç E, Kurumlu Z.
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [Abstract] [Full Text] [Related]

  • 5. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R, Agrawal S, Dhali TK.
    Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
    [Abstract] [Full Text] [Related]

  • 6. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [Abstract] [Full Text] [Related]

  • 7. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A, Lurz C, Hamm H, Bröcker EB, Hofmann UB.
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [Abstract] [Full Text] [Related]

  • 8. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS, Lan CC, Wang LF, Chen GS, Wu CS, Yu HS.
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [Abstract] [Full Text] [Related]

  • 9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W, Nieuweboer-Krobotova L.
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [Abstract] [Full Text] [Related]

  • 10. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ, Dogra S, Parsad D, Kumar B.
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [Abstract] [Full Text] [Related]

  • 11. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
    El Mofty M, Mostafa W, Esmat S, Youssef R, Azzam O, Hunter N, El Hanafi G, Fawzi M.
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
    [Abstract] [Full Text] [Related]

  • 12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [Abstract] [Full Text] [Related]

  • 13. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P, Iuga A, Dacko A, Hardick K.
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [Abstract] [Full Text] [Related]

  • 14. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
    Bansal S, Sahoo B, Garg V.
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
    [Abstract] [Full Text] [Related]

  • 15. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [Abstract] [Full Text] [Related]

  • 16. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
    Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P.
    Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
    [Abstract] [Full Text] [Related]

  • 17. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
    El-Mofty M, Mostafa WZ, Bosseila M, Youssef R, Esmat S, El Ramly A, Fawzi M, Mahgoub D, Nagui N, Mashaly HM, El-Fangary M, Fathy M.
    Dermatol Ther; 2010 Feb; 23(4):428-34. PubMed ID: 20666832
    [Abstract] [Full Text] [Related]

  • 18. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
    Wackernagel A, Legat FJ, Hofer A, Quehenberger F, Kerl H, Wolf P.
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
    [Abstract] [Full Text] [Related]

  • 19. Photo(chemo)therapy for vitiligo.
    Pacifico A, Leone G.
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S.
    J Dermatolog Treat; 2009 Oct; 20(1):14-8. PubMed ID: 18608735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.